Literature DB >> 31240996

Dietary insulin index and insulin load in relation to glioma: findings from a case-control study.

Javad Anjom-Shoae1,2, Mehdi Shayanfar3, Minoo Mohammad-Shirazi3, Omid Sadeghi1,2, Giuve Sharifi4, Fereydoun Siassi2, Ahmad Esmaillzadeh2,5,6.   

Abstract

BACKGROUND: Although hyperinsulinemia is assumed to be involved in brain carcinogenesis, data on the link between dietary insulin index (DII) and dietary insulin load (DIL) and risk of glioma are lacking.
OBJECTIVE: The current study aimed to investigate the relation between DII and DIL and risk of glioma in a case-control study among Iranian adults.
METHODS: In this hospital-based case-control study, 128 pathologically confirmed cases of glioma and 256 age and sex-matched controls were enrolled. Dietary intakes of study participants were assessed using a validated Block-format 123-item semi-quantitative FFQ. DII and DIL were computed using a published food insulin index (FII) data.
RESULTS: A significant positive association was found between DIL and glioma (OR: 3.56; 95% CI: 1.85-6.58, P < 0.001); such that after controlling for potential confounders, participants in the highest quartile of DIL had 2.95 times greater odds of glioma than those in the lowest quartile (OR: 2.95; 95% CI: 1.40-6.24, Ptrend = 0.006). Furthermore, we observed a significant positive association between DII and glioma (OR: 2.65; 95% CI: 1.43-4.93, Ptrend = 0.001). This association remained significant even after considering energy intake (OR: 2.66; 95% CI: 1.43-4.95, Ptrend = 0.001). However, when further potential confounders were taken into account, this relationship became non-significant (OR: 1.87; 95% CI: 0.92-3.80, Ptrend = 0.03), despite a significant trend of increased odds ratios (P = 0.03).
CONCLUSIONS: In conclusion, we found a significant positive association between DIL and odds of glioma. DII was not significantly associated with odds of glioma after controlling for confounders.

Entities:  

Keywords:  Brain tumour; FFQ; case–control study; dietary insulin index; dietary insulin load; food insulin index; glioma; insulin

Mesh:

Substances:

Year:  2019        PMID: 31240996     DOI: 10.1080/1028415X.2019.1631594

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  6 in total

1.  Fruit and vegetable consumption in relation to primary headaches: the MEPHASOUS study.

Authors:  Masoume Mansouri; Farshad Sharifi; Mehdi Varmaghani; Azad Shokri; HosseinAli Rahdar; Abasali Keshtkar; Omid Sadeghi
Journal:  Eat Weight Disord       Date:  2020-08-12       Impact factor: 4.652

2.  The relationship between low-carbohydrate diet score, dietary insulin index and load with obesity in healthy adults.

Authors:  Razieh Karimbeiki; Zahra Namkhah; Elham Alipoor; Mehdi Yaseri; Mohammad Javad Hosseinzadeh-Attar
Journal:  Eat Weight Disord       Date:  2022-08-22       Impact factor: 3.008

Review 3.  The association of dietary insulin load and index with the risk of cancer and cancer mortality: a systematic review and meta-analysis.

Authors:  Farshad Teymoori; Ebrahim Mokhtari; Alireza Bahrami; Hossein Farhadnejad; Mina Azadi; Milad Nazarzadeh; Mohammadreza Vafa
Journal:  J Diabetes Metab Disord       Date:  2022-03-01

4.  Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.

Authors:  Bo Wei; Le Wang; Jingwei Zhao
Journal:  Oncol Lett       Date:  2020-11-19       Impact factor: 2.967

5.  Association of Dietary Insulin Index and Dietary Insulin Load With Metabolic Health Status in Iranian Overweight and Obese Adolescents.

Authors:  Zahra Hajhashemy; Saeideh Mirzaei; Ali Asadi; Masoumeh Akhlaghi; Parvane Saneei
Journal:  Front Nutr       Date:  2022-03-17

6.  The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.

Authors:  Somaye Fatahi; Mohammad Hassan Sohouli; Appaji Rayi; Farshad Teymoori; Farzad Shidfar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.